financetom
Business
financetom
/
Business
/
US utility AES Corp beats third-quarter profit estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US utility AES Corp beats third-quarter profit estimates
Oct 31, 2024 3:22 PM

Oct 31 (Reuters) - AES Corp ( AES ) beat Wall Street

estimates for third-quarter profit on Thursday, driven by higher

earnings from its renewables and utilities segments and a lower

tax rate.

The Virginia-based company saw considerable growth in its

renewables unit last year, driven by a global push for cleaner

power generation, especially at a time when U.S. power demand is

expected to hit record highs.

Its power purchase agreement backlog, which consists of

projects with signed contracts but not yet operational, saw an

uptick to 12.7 gigawatts (GW) from 12.6 GW in the previous

quarter.

Utilities are also projected to see a boom in demand for

electricity over the next decade, primarily due to the power

needs of AI and data centers.

In September, McKinsey estimated that U.S. data center

energy consumption would rise to 606 terawatt-hours (TWh) by

2030, representing 12% of the country's total power demand.

One terawatt-hour can power 70,000 homes for a year.

"Since our last call, we have signed or been awarded 2.2 GW

of long-term contracts for renewable or new data center load

growth at our U.S. utilities," AES ( AES ) Chief Executive Officer

Andres Gluski said.

The utility posted revenue of $3.29 billion for the

July-September quarter, down from $3.43 billion in the same

quarter last year, due to lower sales at its energy

infrastructure unit.

However, earnings in its utilities segment rose 9%, while

those in its renewables segment rose 2.5%.

The company reaffirmed that its full-year adjusted profit

forecast would come in at the upper half of $1.87 per share to

$1.97 per share, driven by new renewables commissionings, rate

base growth, and improved margins in Chile.

AES ( AES ) posted an adjusted profit of 71 cents per share in the

third quarter, compared to analysts' estimate of 64 cents per

share, according to data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved